the effect of cisapride , a new gastrointestinal prokinetic drug , on oesophageal motility and acid reflux was studied in 14 children with gastro-oesophageal reflux disease , receiving either placebo or cisapride 0.15 mg/kg intravenously .
C0017168
gastro-oesophageal
C0072916
cisapride